A once-a-day tablet for obesity could expand the use of weight-loss drugs to many people who have struggled to access them before, experts have said, after a new study found the pill can lead to “significant” reductions in body weight. Almost one in five people taking orforglipron can expect to lose 20% of their body weight after taking the drug for a year and a half, according to a new study.

The new pill is a GLP-1 agonist, a type of medication which helps lower blood sugar levels, slows the digestion of food and can reduce appetite. The weight loss seen among people taking the tablet is not as stark as those among patients taking mounjaro, but experts believe the tablet will be more accessible and convenient compared with weight loss injections.

Mounjaro and the new tablet are both

See Full Page